Press releases worldwide
CeGaT GmbH, a global provider of genetic diagnostics and sequencing services, proudly announces the launch of CancerMRD, a new service for the individualized monitoring of minimal residual disease (MRD) in patients with solid tumors. CancerMRD dynamically tracks changes in disease […]
CeGaT, a global provider of genetic diagnostics and sequencing services, announces significant advancements in exome diagnostics with the latest update to its ExomeXtra® enrichment. The new update is a further step forward in providing innovative solutions to improve patient care. […]
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic testing services across the United States and Canada. Partnerships with numerous commercial insurers further support this strategic expansion, ensuring broad accessibility and insurance […]
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating several events: CeGaT turns 15 years old today. The inauguration of the extension triples the size of the CeGaT building. And furthermore, the family-run […]
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: With the integration of a CNV backbone, it is now possible for the first time to analyze copy number changes in the entire genome […]
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is now using the latest and most powerful sequencing system from Illumina. With the NovaSeq™ X Plus, CeGaT can carry out research projects previously considered […]
CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the first provider in Germany that has equipped its sequencing laboratory with the PacBio system. The Single Molecule Real-Time (SMRT) technology behind it allows […]
CeGaT, a global provider of sequencing services for research, clinical trials and human genetic diagnostics, is expanding its NGS laboratory with the brand new NovaSeq™ X from Illumina. This strategically important step enables CeGaT to serve the growing global demand […]
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is investing in new NovaSeq 6000 sequencing systems from Illumina. This acquisition is a strategically important move given CeGaT’s rapid corporate growth. CeGaT has acquired […]
We are pleased to offer you NGS services accredited according to DIN EN ISO 17025 with immediate effect. The DIN EN ISO 17025 accreditation describes the general requirements for the competence of testing and calibration laboratories and guarantees technically valid […]